Evidence map›Paper›PMID 40833115›Full record

ArticleBiochemical Society transactions2025

Multifaceted roles of mycobacterial HflX: ribosome splitting, rRNA disordering, and drug resistance.

Soneya Majumdar, Pallavi Ghosh, Rajendra K Agrawal

Abstract read
In one paragraph

Article in Biochemical Society transactions, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Soneya MajumdarDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY, 12237, U.S.A.
Pallavi GhoshDivision of Genetics, Wadsworth Center, New York State Department of Health, Albany, NY 12237, U.S.A.
Rajendra K AgrawalDivision of Translational Medicine, Wadsworth Center, New York State Department of Health, Albany, NY, 12237, U.S.A.ORCID 0000-0001-9392-0065

Funding

Alternative Ribosomes & Antibiotic Tolerance in MycobacteriaR01AI132422 · NIAID · WADSWORTH CENTER · PI RAJENDRA K AGRAWAL, Anil Kumar Ojha · 2017 to 2026
$3.8M
Role of ribosome modulating proteins in conferring Mycobacterium abscessus antibiotic resistanceR01AI155473 · NIAID · WADSWORTH CENTER · PI GHOSH, PALLAVI · 2020 to 2024
$2.4M
NIAID NIH HHS R01 AI132422NIAID NIH HHS R01 AI155473
6 · The paper itself

Abstract

High frequency of lysogenization X (HflX) is an enigmatic protein that has been implicated in rescuing translationally stalled ribosomes and macrolide-lincosamide antibiotic resistance, as well as in ribosome biogenesis. The protein shows significant sequence and structural variation across species, including variation among paralogs within the same organism. Recent cryo-EM structure determination of ribosome-HflX complexes from different eubacterial species has provided important mechanistic clues to HflX function. Mycobacterial HflXs carry a distinct N-terminal extension (NTE) and a small insertion, as compared with their eubacterial homologs, suggesting that the mycobacterial HflX could have distinct functional mechanisms. This article presents a brief overview of these studies highlighting (i) what we have learned from recent multiple mycobacterial ribosome-HflX complex structures and (ii) the roles of mycobacteria-specific segments in ribosomal RNA disordering that leads to ribosome splitting to rescue translation by removing the drug-bound stalled ribosome from the translationally active polysome pool. Future studies needed to resolve some of the outstanding issues related to HflX function and dynamics are also discussed.

Indexed as

ribosome–antibiotic interactionsribosome structurerRNA structure and functionstructural biology

Identifiers

PMID40833115
PMCPMC12493154

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.